Pulse Economics

Pulse Economics is a specialist Australian health economics and market access consultancy supporting pharmaceutical, biotechnology and medical technology companies to achieve reimbursement and patient access. We provide strategic advice and technical expertise across the full reimbursement pathway, including PBAC, MSAC and Prescribed List submissions.

Our services include health economic modelling, cost-effectiveness analysis, budget impact analysis, clinical and economic evidence synthesis, reimbursement strategy, pricing support, and early-stage development advice. We work with sponsors from Phase II and Phase III clinical development through to submission, negotiation and post-listing optimisation.

Pulse Economics is known for delivering commercially focused, evidence-based advice tailored to the Australian funding environment. We help clients align clinical development programs with health technology assessment requirements to reduce reimbursement risk and accelerate PBS or MBS listing.

Our clients include global pharmaceutical companies, emerging biotechs, medical device sponsors and research organisations. We combine deep policy knowledge with practical modelling expertise to support successful funding applications and sustainable access strategies.

Based in Australia, Pulse Economics partners closely with clients to navigate complex reimbursement systems and maximise long-term value.